Bloomberg News

Roche Is Preparing Second Large Dalcetrapib Study, Soriot Says

October 13, 2011

Oct. 13 (Bloomberg) -- Roche Holding AG is preparing a second large study of dalcetrapib, its drug for so-called good cholesterol, in patients at risk of a cardiovascular event, Pascal Soriot, head of the Basel, Switzerland-based drugmaker’s pharma unit, said in a conference call today.

To contact the editor responsible for this story: Naomi Kresge at nkresge@bloomberg.net


Soul Searcher
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus